GLP1 SG 15MG
GLP1 SG (Sema) | 15mg | GLP-1 Receptor Agonist Peptide
For In Vitro Research Use Only — Not for Human or Veterinary Use
Description:
GLP1 SG is a synthetic peptide analog that selectively targets the glucagon-like peptide-1 (GLP-1) receptor, making it widely used in in vitro metabolic research related to appetite regulation, glucose control, and cellular energy balance. Laboratory studies suggest GLP1 SG may influence insulin sensitivity, glycemic pathways, gastric-emptying mechanisms, and adipocyte-metabolic signaling through its sustained GLP-1 receptor activation.
Provided in a 15mg lyophilized format, Semaglutide is suited for advanced laboratory environments investigating metabolic, endocrine, and obesity-related in vitro models.
Specifications:
-
Unit Size: 15mg (lyophilized powder, single vial)
-
Molecular Weight: ~4113 Da
-
Form: Crystalline lyophilized peptide
-
Storage: Store dry at 2°C–8°C. After reconstitution, refrigerate between 2°C–8°C
Application Context:
GLP1 SG is studied for its potential roles in:
-
GLP-1 receptor signaling and appetite-regulation pathways
-
Insulin-secretion enhancement and glycemic-control research
-
Adipocyte signaling and metabolic-rate modulation
-
In vitro obesity, metabolic-syndrome, and fatty-liver model studies
Intended Use:
This compound is intended strictly for qualified laboratory researchers. It is not for human or veterinary consumption and must not be used as a drug, food additive, cosmetic, or household product. It is supplied exclusively for controlled in vitro research applications.